CN
1260-17-9
应用筛选条件
关键词:'1260-17-9'
显示 1-28 共 28 条结果 关于 "1260-17-9" 范围 技术文档
Product Information Sheet -sab4200889
., et al., Annu Rev Microbiol. 73:529–57
(2019).
12. Wrapp D., et al., Science. 367:1260 (2020).
13. Ou X., et al., Nat Commun. 11:1620 (2020).
14. Shang J., et al., PLoS Pathog. 16:e1008392
Data Sheet - SAB4200875
Fung T.S., et al., Annu Rev Microbiol. 73:
529–57 (2019).
12. Wrapp D., et al., Science. 367: 1260 (2020).
13. Ou X., et al., Nat Commun. 11: 1620 (2020).
14. Shang J., et al.
SARS-COV-2-Spike-RBD epitope (480-499)
T.S., et al., Annu Rev Microbiol. 73:529–57
(2019).
12. Wrapp D., et al., Science. 367:1260 (2020).
13. Ou X., et al., Nat Commun. 11:1620 (2020).
14. Shang J., et al., PLoS Pathog. 16:e1008392
Product Information Sheet - A1260
Lett., 552(1), 17-22 (2003).
4. Oxford, J. S., et al., Treatment of epidemic and
pandemic influenza with neuraminidase and M2
proton channel inhibitors. Clin. Microbiol. Infect.,
9(1), 1-14 (2003
SARS-COV-2-Spike-RBD epitope (450-469)
T.S., et al., Annu Rev Microbiol. 73:529–57
(2019).
12. Wrapp D., et al., Science. 367:1260 (2020).
13. Ou X., et al., Nat Commun. 11:1620 (2020).
14. Shang J., et al., PLoS Pathog. 16:e1008392
Data Sheet - SAE2000
D.X., Annu. Rev. Microbiol.,
73, 529-557 (2019).
13. Wrapp, D. et al., Science. 367(6483),
1260-1263 (2020).
14. Ou, X. et al., Nat. Commun., 11(1), 1620
(2020).
15. Shang, J., PLoS Pathog
Data Sheet - SAE2001
D.X., Annu. Rev. Microbiol.,
73, 529-557 (2019).
13. Wrapp, D. et al., Science. 367(6483),
1260-1263 (2020).
14. Ou, X. et al., Nat. Commun., 11(1), 1620
(2020).
15. Shang, J., PLoS Pathog
Data Sheet - SAE2002
D.X., Annu. Rev. Microbiol.,
73, 529-557 (2019).
13. Wrapp, D. et al., Science. 367(6483),
1260-1263 (2020).
14. Ou, X. et al., Nat. Commun., 11(1), 1620
(2020).
15. Shang, J., PLoS Pathog
Quality Control Range Sheet- MCY-112 and MCY-212
Control 1 126 – 263 pg/mL
Control 2 522 – 1084 pg/mL Control 2 467 – 969 pg/mL Control 2 607 – 1260 pg/mL
N-TER/siRNA nanoparticle mediated knockdown of gene expression
720 720 1260 1260
NFS 9 18 25 51 35 71 66 133 166 332
0.5´ N-TER
Buffer
99 90 263 237 397 361 654 587 1094 928
Serum-free
HUVEC medium
108 108 288
Quality Control Range Sheet- MCY-112 and MCY2-212
Control 1 126 – 263 pg/mL
Control 2 522 – 1084 pg/mL Control 2 467 – 969 pg/mL Control 2 607 – 1260 pg/mL
Datasheet - SAB4200873
Fung T.S., et al., Annu Rev Microbiol. 73:529–57
(2019).
12. Wrapp D., et al., Science. 367:1260 (2020).
13. Ou X., et al., Nat Commun. 11:1620 (2020).
14. Shang J., et al., PLoS
Datasheet - SAB4200872
Fung T.S., et al., Annu Rev Microbiol. 73:529–57
(2019).
12. Wrapp D., et al., Science. 367:1260 (2020).
13. Ou X., et al., Nat Commun. 11:1620 (2020).
14. Shang J., et al., PLoS Pathog. 16:e1008392
Datasheet - SAB4200874
Fung T.S., et al., Annu Rev Microbiol. 73:529–57
(2019).
12. Wrapp D., et al., Science. 367:1260 (2020).
13. Ou X., et al., Nat Commun. 11:1620 (2020).
14. Shang J., et al., PLoS
TB029
4117
BbvI 20
BccI 9 231 324 761 850 1157
1169 3176 3300 3587
Bce83I 6 456 626 2337 2635 2876
3744
BcefI 3 381 938 2748
BcgI 8 34 468 502 1823 1857
3644 3678 4134
BfaI 6 38 83 1260 2741
Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality
8
9
107
11
12 14
15
13
16
17
18
19
Figure 29. Amino Acids on SLB-5ms
4.0 5.0 6.0 7.0 8.0Min
1
2
3 4
5
6 7
Paper: Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: Confirming a non-pancreatic etiology
://doi.org/10.1007/s00125-010-1798-5
https://doi.org/10.1007/s11695-014-1260-8
https://doi.org/10.1007/s11695-014-1260-8
https://doi.org/10.1002/oby.21042
https://doi.org/10.1002/oby.21042
Protocol: Human Leptin
15 12.5 ng/mL 3354 3354 2631 0.381
16 3354
17 25 ng/mL 2373 2449 1726 0.250
18 2525
19 50
Protocol: Human Leptin RIA Kit
12.5 ng/mL 3354 3354 2631 0.381
16 3354
17 25 ng/mL 2373 2449 1726 0.250
18 2525
ChemiScreen™ cAMP -Optimized Stable Cell Line Human Recombinant D2L Dopamine Receptor
400
1201 - TGC AAC ATC CCG CCT GTC CTG TAC AGC GCC TTC ACG TGG CTG GGC TAT GTC AAC AGC GCC - 1260
401 - C
Protein Tyrosine Phosphatases- Potential Roles in Disease
al., J. Leukoc. Biol. 64, 692-701(1998).
50. McArdle, L., et al., J. Invest. Dermatol., 117, 1255-1260 (2001).
51. Shultz, L.D.., et al., Trends Biotechnol., 15, 302-307 (1997).
®
®
O
r
d
e
Katalog OHAUS
VE1500P 1500 kg 1260 x 840 mm 80251476 926
Model Váživost Dílek (d=e) Váž. plošina Obj. číslo Cena €
VE1500P31P 1500 kg 500 g 1260 x 840 mm 80251858 1066
VE1500P31P-M 1500 kg 500 g
PureFlex™ and PureFlex™ Plus White Paper
-methyl-1-propene(TIC) 115-11-7 247
3,3-dimethyl 2-butanone(TIC) 75-97-8 1260
Pentanal (TIC) 110-62-3 39
2-pentanone 107-87-9 81
2,4-Di-tert-butylphenol 96-76-4 1110
50% EtOH yes none N/A N/A
Application Notes Polar Hydrophilic Compounds in Pharmaceutical Analysis Part II
μm, 100 Å) PEEK 150 × 2.1 mm 1.50658.0001
Injection: 1 μl
Detection: Agilent 1260, ELSD
Flow Rate: 0.2 mL/min
Mobile Phase (v/v):
Polar Hydrophilic Compounds in Pharmaceutical Analysis (MM version 2013)
150x4.6 mm 1.50455.0001
Injection: 10
Katalog neoLab
200 pcs./pack
9-0160 4 ml amber 15 x 45 mm 13 mm 200 pcs./pack
9-0153 8 ml clear 17 x 60 mm 15 mm 200 pcs./pack
9-0161 8
Chrombook (WEB-Version)
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
0 10 20 25 30 355 15 RT [min]
1
3
4
5
6
XP725 Worksheet for Lot Number 071M4826
3 1 8 Rad17 R8029
1257 7 3 2 1 Raf1cRaf R2404
1258 7 3 2 2 Raf1cRaf R2404
1259 7 3 2 3 Raf1 R5773
1260 7 3 2 4 Raf1 R5773
http://www.sigmaaldrich.com/ProductLookup.html?ProdNo=P7854&Brand=SIGMA�